secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED GUARDIAN INC (UG)
CIK:        0000101295
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001171843-25-007076
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United-Guardian Q3 revenue down 26% YoY; net income falls 69% to $0.06 EPS
--------------------------------------------------------------------------

- Q3 2025 revenue $2.26M vs $3.06M in Q3 2024; net income $268K vs $865K.
- Nine-month revenue $7.58M (-22%); net income $1.46M (-47%); EPS $0.32 vs $0.60.
- Decline driven by reduced orders from ASI for cosmetic ingredients due to tariff/geopolitical issues.
- Pharmaceutical and medical sales rose 10% and 6% respectively in first nine months.
- Company advancing Renacidin formulary inclusion project to boost pharmaceutical revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/101295/000117184325007076/0001171843-25-007076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/101295/000117184325007076/f8k_110425.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-007076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer